Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective. Go to Publication You Might Also Like The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020 Resistance to second-line drugs in multidrug-resistant tuberculosis. February 23, 2013 Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease August 30, 2019 Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017 The association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. March 3, 2013
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017
The association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. March 3, 2013